Study on the mechanism of intestinal microbiome in attention deficit hyperactivity disorder

Study on the mechanism and potential intervention strategies of intestinal microbiome in attention deficit hyperactivity disorder

Status

Recruiting

Phases

Early Phase 1

Study type

Observational

Source

ChiCTR

Registry ID

ChiCTR2100054232

Enrollment

Unknown

Registered

2021-12-11

Start date

2021-12-30

Completion date

Unknown

Last updated

2022-11-14

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Attention deficit hyperactivity disorder (ADHD)

Interventions

ADHD group:No

Eligibility

Sex/Gender

All

Age

6 Years to 14 Years

Inclusion criteria

Inclusion criteria: 1. Children were selected from the Children's Hospital of Chongqing Medical University from October 2021 to March 2022 who were diagnosed as ADHD for the first time by physicians with the title of attending or above according to dSM-V diagnostic criteria. 2. Aged 6-14 years. 3. In the past 2 weeks, patient has not used any ADHD drugs, such as Children Huanglong granules, nerve stimulants, non-central stimulants, tricyclic antidepressants and antibiotics. 4. Sign informed consent and be willing to take the test.

Exclusion criteria

Exclusion criteria: 1. Complicated with organic diseases of the nervous system, mental retardation, autism spectrum disorder, anxiety and depression disorder, and serious cardiovascular/digestive diseases. 2. Patients with clinical manifestations similar to ADHD due to intellectual disability, but excluding learning difficulties, oppositional defiant, behavioral disorders, and tics.

Design outcomes

Primary

Measure	Time frame
Genus of intestinal bacteria;	—

Countries

China

Contacts

Public ContactChen Chengzhi

Chongqing Medical University

chengzhichen@cqmu.deu.cn+86 15123969906

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026